CG Oncology discloses 2023 executive bonuses in amended summary comp table

CG Oncology, Inc.

CEO Arthur Kuan awarded $189,000 performance bonus for 2023; total comp $3.93M.
COO Ambaw Bellete received $189,500 sign-on bonus plus $179,740 performance bonus; total $3.03M.
CMO Vijay Kasturi received $56,000 sign-on bonus plus $87,448 performance bonus; total $2.44M.
Bonuses omitted from Jan 2024 IPO prospectus; now reported in Item 5.02 filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.